Abstract
Intravenous glucagon was studied as a premedicative drug for endoscopic retrograde cholangiopancreatography with butropium bromide as a control drug. As results the following were observed. 1) There were no differences in the peristalsis of the stomach and in the hypotonicity and peristalsis of the duodenum between glucagon and butropium bromide. 2) Concerning side effects, dry mouth, accommodation disturbance, dysuria, abdominal pain and palpitation were frequently observed in the butropium bromide group. 3) It was confirmed glucagon can be used as a premedicative drug for an endoscopic retrograde cholangiopancreatography as well as anticholinergic drugs, and also for cases in which the anticholinergic drugs are contraindicated. Glucagon will be widely applied in this area because it has few side effects.
